← Open Payments lookup

PHEBA PAPPACHAN: Open Payments

NPI 1053757179 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$203 in 6 payments from 6 companies in 2025. Trend: 2023 $102 · 2024 $226 · 2025 $203

Food & beverage: $203
CompanyPaymentsAmount
Alkermes, Inc.1$84
Lundbeck LLC1$31
ABBVIE INC.1$29
Vanda Pharmaceuticals Inc.1$22
Luye Pharma (USA) Ltd.1$20
Averitas Pharma Inc.1$17

Products named: ARISTADA, REXULTI, VRAYLAR, FANAPT, ERZOFRI EXTENDED-RELEASE, QUTENZA.

Industry payments across TX — which companies pay providers there.